Related Experiment Video
Updated: Jun 16, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Retroperitoneal soft tissue sarcomas: experience at a single institution in Mexico
Luis García-Aceituno1, Cynthia Villarreal-Garza, Miguel Perfecto
1Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15 Seccion XVI Tlalpan, 14000, Mexico City, Mexico. lgarcia.aceituno@gmail.com
World Journal of Surgery
|February 18, 2010
Summary
Retroperitoneal soft tissue sarcomas (RSTS) survival is poor, with 5-year OS around 50%. Complete surgical resection is the primary treatment for RSTS, as incomplete resection and advanced stages significantly reduce survival rates.
Area of Science:
- Oncology
- Surgical Oncology
- Sarcoma Research
Background:
- Retroperitoneal soft tissue sarcomas (RSTS) are rare malignancies with historically poor prognoses.
- Despite low metastatic potential, 5-year overall survival (OS) for RSTS is approximately 50%.
Purpose of the Study:
- To analyze the survival outcomes of patients diagnosed with RSTS.
- To identify prognostic factors influencing survival in RSTS patients.
Main Methods:
- Retrospective analysis of 46 RSTS patients treated between 1990 and 2008.
- Evaluation of clinicopathological variables including age, sex, histology, TNM stage, tumor size, grade, and treatment modalities.
- Analysis of overall survival (OS), recurrence-free survival (RFS), and cancer-specific survival (CSS) based on resection status (R0, R1, R2), tumor grade, and stage.
Main Results:
- The 5- and 10-year OS rates for the entire cohort were 47% and 30%, respectively.
- Complete resection (R0) was achieved in 59.4% of surgically treated patients, with a 5-year OS of 81%.
- High histological grade, advanced TNM stage, and incomplete resection were significantly associated with poorer survival outcomes.
Conclusions:
- Complete surgical resection is the cornerstone of treatment for RSTS.
- Factors such as high grade, advanced stage, and incomplete resection are critical determinants of poor survival in RSTS patients.
